Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer (InForma)

January 29, 2020 updated by: European Institute of Oncology

Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer: A Four-arm Randomized Trial

The investigators aim to evaluate the effect of a 6-month intervention (counseling) focused on weight loss in a group of overweight or obese women previously treated for early breast cancer. Intervention is designed to improve adherence to a healthy diet or/and to increase physical activity and decrease sedentary time, taking advantage of a pedometer-like device.

Study Overview

Detailed Description

The InForma project is designed as a mono-institutional randomized controlled 4-arm parallel-group trial. Potential study participants will be recruited among all overweight or obese breast cancer patients previously treated at the European Institute of Oncology (IEO). Potential study participants will be recruited after breast cancer treatments (surgery, chemotherapy and and/or radiation) will be completed. Study participants will be randomized to one of the 4 arms: DI - Dietary Intervention; PAI - Physical Activity Intervention; PADI - Physical Activity and Dietary Intervention; LII - Less Intensive Intervention. Enrolled patients will receive a 6-month intervention and will be followed until the end of the study period with two additional follow-up visits at 12- and 24-month. The main aim of the study is to evaluate the impact of the intervention programme on body weight change in overweight or obese breast cancer patients.

Study Type

Interventional

Enrollment (Actual)

262

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy, 20141
        • IEO Istituto Europeo di Oncologia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • diagnosed with a first invasive non-metastatic breast carcinoma histologically confirmed,
  • BMI > 25,
  • within 6-month/one year of completion of main cancer treatment,
  • being able to participate in the intervention,
  • agree to wear the wrist-based activity monitor during the study period,
  • agree to be randomized to either group,
  • written informed consent.

Exclusion Criteria:

  • severe medical condition or advanced age impeding the patient to adhere at the planned study follow-up period,
  • contraindications to exercise due to history of heart condition, stroke, chest pain during activity or rest, severe hypertension
  • orthopaedic disability that would prevent optimal participation in the physical activities prescribed,
  • patient is unable to find transportation to the study location over the study period, - or
  • plans to move away from Lombardy or to be out of town for more than 3 weeks during the study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: DI Dietary Intervention
Individualized dietary counselling to reduce body weight
Participants will be offered an individualized dietary counselling according to their lifestyle habits to reduce weight consisting of face-to face contacts, group meetings, motivational phone calls and information pamphlets.
Other Names:
  • Dietary Intervention
EXPERIMENTAL: PAI Physical Activity Intervention
Individualized physical activity counseling to reduce body weight
Participants will be offered an individualized physical activity counseling according to their lifestyle habits to reduce weight consisting of face-to face contacts, group meetings, motivational phone calls and information pamphlets.
Other Names:
  • Physical Activity Intervention
EXPERIMENTAL: PADI Physical Activity+Diet Intervention
Individualized dietary and physical activity counseling to reduce body weight
Participants will be offered an individualized dietary and physical activity counseling to reduce weight consisting of face-to face contacts, group meetings, motivational phone calls and information pamphlets.
Other Names:
  • Physical Activity and Dietary Intervention
EXPERIMENTAL: LII Less Intensive Intervention
Materials and guidelines available to general public
Participants will be considered as control group. They will receive a general healthy counselling providing materials and guidelines available for the general public.
Other Names:
  • Less Intensive Intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight reduction
Time Frame: baseline - 6 month
weight loss ≥5% of the baseline body weight via calibrated scales, stadiometer
baseline - 6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Long-term body weight control
Time Frame: baseline - 12 month - 24 month
long-term weight control or maintenance via calibrated scales, stadiometer
baseline - 12 month - 24 month
Pedometer Step Count
Time Frame: baseline - 6 month - 12 month - 24 month
change in total step count via pedometer device with electronic data transmission
baseline - 6 month - 12 month - 24 month
Physical activity level
Time Frame: baseline - 6 month - 12 month - 24 month
change in physical activity and inactivity levels via IPAQ-International physical activity questionnaire
baseline - 6 month - 12 month - 24 month
Dietary intake
Time Frame: baseline - 6 month - 24 month
change in dietary intake via Food Frequency Questionnaire
baseline - 6 month - 24 month
Quality of life
Time Frame: baseline - 6 month - 12 month - 24 month
change in quality of life via Functional Assessment of Cancer Therapy-Breast (FACT-B)
baseline - 6 month - 12 month - 24 month
Mood
Time Frame: baseline - 6 month - 12 month - 24 month
change in mood via State-Trait Anxiety Inventory (STAI) questionnaires
baseline - 6 month - 12 month - 24 month
Lipid Marker Change
Time Frame: baseline - 6 month - 24 month
change in LDL, HDL, triglycerides and cholesterol assessed by blood samples
baseline - 6 month - 24 month
Oestradiol level
Time Frame: baseline - 6 month - 24 month
change in oestradiol assessed by blood samples
baseline - 6 month - 24 month
Insulin level
Time Frame: baseline - 6 month - 24 month
change in insulin assessed by blood samples
baseline - 6 month - 24 month
Glucose level
Time Frame: baseline - 6 month - 24 month
change in glucose assessed by blood samples
baseline - 6 month - 24 month
C-reactive protein level
Time Frame: baseline - 6 month - 24 month
change in C-reactive protein assessed by blood samples
baseline - 6 month - 24 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrick Maisonneuve, European Institue of Oncology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2015

Primary Completion (ACTUAL)

June 30, 2019

Study Completion (ACTUAL)

June 30, 2019

Study Registration Dates

First Submitted

November 6, 2015

First Submitted That Met QC Criteria

December 2, 2015

First Posted (ESTIMATE)

December 4, 2015

Study Record Updates

Last Update Posted (ACTUAL)

January 30, 2020

Last Update Submitted That Met QC Criteria

January 29, 2020

Last Verified

January 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on DI

Subscribe